{
    "nctId": "NCT04137744",
    "briefTitle": "Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection",
    "officialTitle": "Evaluation of Axillary Reverse Mapping (ARM) in Clinically Axillary Node Negative Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Arm Lymphedema, Lymphatic Spread of Breast Cancer, Early Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 74,
    "primaryOutcomeMeasure": "histopathologic examination of ARM +ve LN",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* clinically free breast cancer\n* sentinle LN positive\n\nExclusion Criteria:\n\n* patients on chemotherapy for breast cancer\n* recurrent cases after conservative breast surgery\n* bilateral disease and pregnant cases",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}